Report License

$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off

Order Review

Alzheimer’s Therapeutics Market – By Drug Class (Cholinesterase Inhibitors, NMDA, Combination Drugs, Glutamate, MAO), Route of Administration (Oral, Injectable, Transdermal), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) & Forecast, 2024 – 2032

Report ID: GMI10124
Selected License: $8,350
Discount: $2,505
Order Total: $5,845

Need assistance?

Call us or write to us:

What You Get?

Billing Information

Payment Method


creditCardImage
Top